Opsens (TSX:OPS) Research & Development : C$11.31 Mil (TTM As of Aug. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Opsens Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Opsens's Research & Development for the three months ended in Aug. 2023 was C$2.84 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Aug. 2023 was C$11.31 Mil.

Opsens Research & Development Historical Data

The historical data trend for Opsens's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens Research & Development Chart

Opsens Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Research & Development

Get a 7-Day Free Trial

4.80

5.44

5.51

8.36

11.31

Opsens Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Research & Development	Get a 7-Day Free Trial															2.24	2.47	2.49	3.52	2.84

Opsens Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$11.31 Mil.

Opsens (TSX:OPS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Opsens Research & Development Related Terms

Thank you for viewing the detailed overview of Opsens's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Opsens (TSX:OPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3

Website

https://www.opsens.com

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.

Executives

Alan Milinazzo	Director
Robin Villeneuve	Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.)	10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines